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THE experiment described below was designed specifically to test whether the
incidence ofmalignant tumours in mice treated with a small dose of 9,10-dimethyl-
1,2-benzanthracene (DMBA) followed by a course of croton oil could be increased
by splitting the dose ofthe former into two halves. Five test groups, in which the
interval between the application of the two half doses ranged between 1 hour
and 10 weeks, were set up. Another group was given the same dose of DMBA
in a single application. On the assumption that the malignant condition is the
result of two or more successive changes in a susceptible cell, it is to be expected
that two applications of a carcinogen are more likely to produce it than one. It
was hoped that the above experiment would show whether the division of an
initiating dose ofDMBA into two halfdoses favoured the appearance ofmalignant
tumours (after subsequent promotionby crotonoil) and, ifso,what was theoptimal
interval between the half doses.
MATERIALS AND METHODS
These were essentially the same as those described in the first paper of this
series (Roe, 1956a).
EXPERIMENTAL
Sixty male and 60 female mice were divided into 6 equal groups consisting of
10 mice of each sex.
As shown in Table I, all groups received treatment with DMBA and croton oil,
and the total doses of both substances applied was the same throughout. Mice of
Group 1 received a single application of DMBA on the first day of the experiment.
Mice ofGroups 2 to 6receivedthe samedose ofDMBAdividedintotwoapplications
(by halving the concentration), one on the first day and the second after intervals
of 1 hour, 1 day, 4 days, 3 weeks, and 10 weeks, respectively. In all 6 groups
weekly application of croton oil was begun on the 92nd day of the experiment,
and stopped when 15 applications had been given.
Mice were examined for the presence of tumours, and the numbers seen were
charted weekly, until one week after the final application of croton oil.M. H. SALAMAN AND F J. C. ROE
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0DEVELOPMENT OF TUMOURS OF MOUSE SKIN
All the survivors at the end of croton oil treatment were kept and examined
regularly, and special note was made of tumours which showed any of the naked-
eye appearances suggestive of malignancy. The criteria used have been described
(Roe, 1956a). As soon as it was considered that a tumour was definitely malignant,
the mouse was killed.
Post-mortem examination was carried out on all mice which were killed because
of malignant skin tumours, or because of loss of condition from other causes.
Skin tumours were counted, pictorial charts made oftheir position and appearance,
and the pelts preserved. Sections were later taken of all tumours which appeared
malignant, or possibly malignant, and from many apparently benign tumours as
well. After this selection had been examined histologically, another survey of the
pelts was made: the largest remaining tumours were taken from all malignant-
tumour-bearing pelts and from a similar number of pelts on which no malignant
tumour had previously been detected.
In addition to tumours, lymph glands draining sites ofmalignant tumours, and
organs which showed any pathological changes, were sectioned.
RESULTS
1. Incidence of malignant tumours
Of the 106 mice which survived until one week after the final (15th) weekly
application ofcroton oilno less than 43 (405 per cent) laterdeveloped histologically
malignant tumours, the criterion of malignancy being penetration by the tumours
of the panniculus carnosus (Roe, 1956a). Of these, 6 mice bore 2 malignant
tumours each. Thus a total of 49 malignant tumours of the skin were observed.
Ofthese, 40 were carcinomata and 9 were spindle-celled sarcomata. Considerable
difficulty was encounteredin makingthis distinction in some cases, foralthough the
epithelial origin of the majority of the carcinomata was not in doubt, a few
consisted almost entirely of undifferentiated spindle-shaped cells. One such
tumour was thought to be a sarcoma until an obviously carcinomatous metastasis
was observed in the regional lymph node. In the final assessment early naked-eye
appearances were taken into account: only those tumours which arose and
expanded subcutaneously, with or without someultimate ulceration, and which
hadthehistologicalappearance ofspindle-cell sarcomata, wereclassedassarcomata.
Most tumours which proved to be obvious carcinomata histologically had shown
early ulceration and typically undermined edges. In those which had shown these
naked-eye characteristics, but which were later found to consist ofundifferentiated
spindle-cells, it always proved possible to discover, after prolonged microscopical
examination, small foci of cells indubitably of epithelial origin. The 9 sarcomata
were distributed fairly evenly throughout the groups (1, 2, 1, 3, 1, and 1, in Groups
1 to 6 respectively) and occurred in both sexes (5 in males and 4 in females).
Metastases were seen in the regional lymph nodes of 4 mice. One of these,
which bore both a carcinoma and a sarcoma, had a carcinomatous deposit in the
regional lymph node and sarcomatous deposits in the spleen, liver, and heart.
Another had a carcinomatous metastasis in the lung in addition to one in the
regional lymph node.
In addition to the 49 frankly malignant tumours we observed a further 20
"probablymalignant " tumours (Roe, 1956a). Thedistribution ofthesethroughout
the groups and between the sexes is shown in the final column ofTable I. Eighteen
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of these 20 tumours were of epithelial, and 2 of connective tissue, origin ; 11
occurred in mice which had one or more definitely malignant tumours in addition.
Examination of sections from the second survey of the pelts, referred to above
(p. 81), resulted in the discovery of no more definitely malignant, and only 4
more ' probably malignant " tumours; these are included in the figures given
above. This result shows that no great underestimate ofthe incidence ofmalignant
tumours had been made in the first survey, and that the final figures are not in
serious error.
2. Effect on incidence of malignant tumours of dividing the initiating dose into two
halves
The numbers of malignant tumours, and of malignant tumour-bearing mice
in Groups 1 to 6 are shown in Table I. Groups 5 and 6 developed more malignant
tumours than any of the other groups. Similarly the numbers of " probably
malignant" tumours, given in the last coluimn of the table, are also highest in
these groups. Table I shows that the average survival in Group 1 was far better
than that in any other group. Nevertheless the incidence of malignant and
" probably malignant " tumours, and the number of malignant tumour-bearing
mice, in Group 1 are as low as, or lower than, in any other group.
Table I also shows the mean latent period before the appearance of malignant
tumours in the six groups. The time of appearance of a malignant tumour was
arrived at retrospectively (Roe, 1956a). Despite the fact that half the total dose
of DMBA was given later, malignant tumours in Groups 4 to 6 tended to arise as
early or earlier than those in Groups 1 to 3.
Broadly speaking these results suggest that the incidence ofmalignant tumours
after two half-doses ofDMBA with an interval of 22 days or more (Groups 5 and 6)
is greater than that after a single full dose (Group 1), or two half-doses with an
interval of 4 days or less (Groups 2, 3, and 4).
It is clearly desirable to analyse the results by a statistical method which takes
into account not only the incidence of malignant tumours (or malignant-tumour
bearing mice) but also the times at which malignant tumours arose, and the
survival rate of mice in different groups.
The method which approached most closely to satisfying these requirements
was the estimation of the " expectation of tumourless life " described by Irwin
and Goodman (1946), and Irwin (1949). However this method takes into account
only the first tumours to appear on each animal, and was designed for the analysis
of the results of experiments in which 100 per cent of surviving animals developed
tumours before the end ofthe period ofobservation. In the experiments described
in the present paper to ignore the occurrence of multiple tumours on the same
mouse would be to discard valuable data. Moreover the proportion of surviving
mice which bore malignant tumours never exceeded 50 per cent. For these
reasons, and especially for the second, it was not found possible to give statistical
expression to the differences between our groups by Irwin's method. No other
statistical method has proved suitable.
3. Sex difference in incidence ofpapillonata and malignant tumours
At the end of croton oil treatment the 52 male survivors bore 801 papillomata,
while the 54 female survivors bore only 473. In none of the 6 groups did the inci-
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dence ofpapillomata infemales exceedthat in males. Ofthe 49 malignant tumours,
however, 22 were borne by males and 27 by females, and of 20 " probably
malignant " tumours, 12 were borne by males and 8 by females. Thus, in spite of
a marked sex difference in incidence of papillomata, the incidence of malignant
tumoturs was almost the same in the two sexes.
4. The regression of papillomata in mice with malignant tumours
It has been stated (Shubik, 1950) that when a mouse develops a malignant
tuiniour of the skin, many of its papillomata regress.
In the present experiment, the papilloma-regression rate was 10 per cent in the
43 mice which developed malignant tumours, and 17 per cent in the 58 which did
not (mice with " probably malignant ", but no definitely malignant, tumours
were excluded from both categories).
This finding confirms that recorded in the first paper ofthis series (Roe, 1956a),
and has already been referred to there. Thus there is no evidence from our results
in suipport of Shubik's contention.
DISCUSSION
The experiments recorded in this series offour papers were undertaken with the
object ofresolving certain doubts which had arisen in the course of previous work
on carcinogenesis. The clear-cut conception of Berenblum and Shubik, outlined in
their classical papers (Berenblum and Shubik, 1947a, 1947b, 1949), have stimulated
research on the stages of carcinogenesis in many laboratories, and still form the
basis of much of our thought on this problem. It has been becoming increasingly
clear, however, to those engaged in the investigation of the action of initiating
and promoting agents that the original hypothesis of Berenblum andShubikshould
be re-examinedinthelightofsubsequentobservations. Shubikhimselfhasproposed
certain modifications (Shubik, 1950; Shubik and Ritchie, 19.53) to cover new
facts not apparently in harmony with the theory in its original form.
Berenblum and Shubik based their hypothesis on two important findings:
(1) the tumour incidence curve in mouse-skin treated with an initiating, followed
by a promoting, agent " rapidly reaches a set level, well below 100 per cent, and
remains at that level however long croton oil treatment is continued" and (2)
this level varies with the specific potency and the concentration of the initiating
agent, and is independent of the length of the interval between the initiating
treatment and the beginning of the promoting treatment. To explain these
observations theypostulated that the " initiating " stimulus brought into existence
a definite number of " latent tumour cells ", that these remained dormant, without
increase or decrease, till the promoting stimulus was applied, that thereafter each
" latent tumour cell " gave rise to a tumour, and that when all had done so no
more tumours appeared.
The argument depended for its validity on the results oftwo important control
tests. It was found that neither the initiating stimulus nor the promoting stimulus
produced any tumours when used alone, under similar experimental conditions.
In the case of the initiating agents used by Berenblum and Shubik, all of which
were carcinogenic hydrocarbons, this result depended on the choice of what
83M. H. SALAMAN AND F. J. C. ROE
wasthought to be a sub-carcinogenic dose. The promoting agent, croton oil, was
believed to be virtually devoid oftumour-producing power.
Experience in this laboratory has indicated that the clear-cut results of these
control tests of Berenblum and Shubik's were exceptional. Significant numbers of
papillomata have been observed after treatment of mouse-skin with DMBA, in
even smaller doses than they used, without any subsequent treatment (Salaman
and Gwynn, 1951 ; Roe, 1956a). Similarly papillomata have been seen after
applications of croton oil, fewer in number and at lower concentrations than in
their tests, without previous treatment with an initiator (Roe and Salaman,
1955; Boutwell, Rusch and Bosch, 1955; Roe, 1956b).
Furthermore, the theory in its original form took no account of the variety of
tumours produced, of the benign-malignant change (though some qualitative
suggestions on this matter had previously been made by Berenblum (1941)), nor
of the gradual development in autonomy and other characters, now known as
" progression " (Foulds, 1954), which might be expected to occur in skin tumours,
as in others. In an attempt to cover this field Shubik and his colleagues (Shubik,
1950; Shubik, Baserga and Ritchie, 1953), on the basis of a survey of the types
ofskin tumoursproducedbysingle andmultipledoses ofcarcinogenichydrocarbons
with or without subsequent treatment with croton oil, concluded that the varying
properties of these tumours and their potentialities for gradual change, including
the development of malignancy, should be regarded as determined by the
" initiating stimulus ". He speaks of the process of initiation as " a graded one,
inducing changes in growth potentialities in latent tumour cells ". The function of
the promoting agent he regarded as merely that ofrevealing this " series ofgraded
lesions, varying in growth-potential ".
Recent observations in this laboratory and elsewhere suggest that this concept
also will have to be modified. Repeated applications of croton oil (only) produce
not only considerable numbers of papillomata, but some malignant tumours as
well (Roe, 1956b; Boutwell, Rusch, and Bosch, 1955). Since croton oil has this
power, the possibility that it may influence the progression of characters in
tumours when used after an initiating stimulus cannot be dismissed.
Another aspect of the results of Berenblum and Shubik (1947a, 1947b, 1949)
raised doubt whether a theory based on what happens after the successive applica-
tion of initiating and promoting stimuli is applicable to the problem of carcino-
genesis in general. All the tumours described in these reports were of a benign
character. Shubik's later studies (Shubik, 1950) showed that malignant tumours
did arise in mice treated once with a carcinogenic hydrocarbon followed by croton
oilrepeatedly, but that theirincidence wasverymuchless thaninmicetreatedwith
the hydrocarbon repeatedly. Allsopp (1951) thought that croton oil might even
have an inhibitory effect on the transition of tumours from benign to malignant.
A search for the reasonfor this difference in the incidence ofmalignant tumours
after the two forms of treatment (i.e. initiating dose of a carcinogen followed by
croton oil, and the carcinogen applied repeatedly) were among the objects of the
present series of experiments. In the first place it was necessary to confirm that
there was a real difference in incidence of malignant tumours between mice given
these two forms of treatment. Previous reports relied on relatively short periods
of observation. The first and fourth papers of this series report experiments in
which mice were given a single application of DMBA followed by a course of
croton oil treatment, and kept under observation till death (Roe, 1956a, Groups
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5 and 6; present paper, Group 1). It was found that malignant tumours began
to appear after a long latent interval (24 to 36 weeks), and thereafter continued to
appear till death. The average latent interval between the beginning of the
experiment and the appearance of malignant tumours was longer than the mean
survival time, which suggests that if the mice had lived longer the incidence of
malignant tumours would have been considerably greater. Notwithstanding this,
the incidence of malignant tumours, however reckoned, was significantly less than
in mice given repeated applications of DMBA (Salaman and Roe, 1956, Group 1).
In the second place, evidence was sought on the question whether there was a
correlation between the incidence of papillomata and the incidence of malignant
tuminours in mice treated with an initiating dose of a carcinogen followed by croton
oil. When the numbers of benign and malignant tumours borne by individual
miice were compared it was found that there was a significant positive correlation
between them. This correlation held for individual mice, but not for groups of
mice as a whole. (It has often been observed that the incidence of papillomata
varies considerably between different groups of mice similarly treated (Berenblum
and Haran, 1955; and unpublished data from this laboratory). This may be due
to such conditions as age, sex, and proportion of highly susceptible mice, which
affect groups of mice as a whole. But there is no reason to think that such
conditions have a similar effect onthe incidence ofmalignant tumours. Forinstance,
in the present paper, the incidence of papillomata was considerably higher in
males than in females, but they both had approximately the same incidence of
malignant tumours.) Despite the variation between groups in the incidence of
papillomata, it remains true that within a group of mice treated in a particular
way, a mouse which bears many papillomata is more likely to develop malignant
tumours than one which bears few or none.
An observation ofShubik is relevant to this question. He states (Shubik, 1950)
that when a mouse develops a malignant tumour ofthe skinmany ofitspapillomata
regress. We were unable to confirm this finding (Roe, 1956a, p. 67).
In the third place, the possibility was tested that croton oil inhibits the produc-
tion of malignant tumours, as suggested by Allsopp (1951). No support for this
suggestion was found (Salaman and Roe, 1956): application of croton oil actually
increased (though not significantly) the incidence of malignant tumours in mice
treated repeatedly with DMBA.
In the fourth place an experiment (reported in the present paper) was planned
to test the possibility that the actual multiplicity of stimuli, or the fact that they
were applied over a period, were factors in increasing the incidence of malignant
tumours in mice treated with a carcinogen repeatedly. It may be argued that in
experiments such as that of Shubik (1950) mice given repeated applications of a
carcinogen receive a far greater total dose ofit than mice given a single application
of the carcinogen followed by croton oil, and that this accounts for the fact that
they are more likely to develop malignant tumours. In planning the experiment
described in the present paper thepossible influence ofthis factor was eliminated by
keeping the total dose of carcinogen constant. If the multiplicity and spacing of
stimuli proved to be factors determining the incidence of malignant tumours,
this could be explained by postulating that the malignant condition is the result
of two or more successive events in the same cell; these would be less likely to
occur in a cell subjected to one application of a carcinogen than to two or more.
There was no means ofknowing beforehand the optimalnumber ofapplications
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nor the optimal interval between them. The experiment, therefore, was essentially
of a preliminary nature, with its main objective to set the conditions for a more
comprehensive study. The results were, in fact, not inconsistent with the view
that splitting of an initiating dose of DMBA increases the incidence of malignant
tumours, especially when the interval between the two half-doses is three weeks or
longer. It was not possible, however, through lack ofa suitable statistical method,
to be sure whether the differences were significant. The fact that some malignant
tumours do arise following a single initiating dose of DMBA, with or without
subsequent treatment with croton oil, does not invalidate the theory of serial
changes, for it is possible that two successive stimuli might be delivered to the
same cell during the period of persistence of the carcinogen in the skin. Further
work will, however, be needed to prove or disprove the theory that the malignant
change can only be initiated by serial stimuli.
In the first paper ofthis series (Roe, 1956a) it was shown that a single applica-
tion of 0 3 mg. ofDMBA without further treatment resulted in a small but definite
incidenceofmalignanttumours, andinthethirdpaper (Roe, 1956b),thataprolonged
course of weekly applications of 0 5 per cent croton oil alone also produced some
malignant tumours. Is it possible that the combined incidence of these two, by
simnple summation, could account for the incidence of malignant tumours seen in
mice which received both treatments successively ? Examination of the results
shows that this is unlikely. Six malignant tumours were seen in 60 mice following
a single application ofDMBA after a mean latent interval of 55-3 weeks (SD -+
4*7 weeks). All 6 tumours were on the head or face, i.e. outside the treated area.
The comparable incidence following 18 weekly applications of croton oil was nil
(though 7 malignant tumours appeared on 6 out of 20 mice after from 55 to 72
weekly applications). After a single application of DMBA followed by 18 weekly
applications of croton oil 13 malignant tumours appeared on the treated area of 8
out of 30 mice, with an average latent period of 46-3 weeks (SD ± = 2-5 weeks),
only one malignant tumour being outside the treated area (after 53 weeks). Thus
the incidence of malignant tumours in mice given the combined treatment was
greater than can be accounted for by simple summation of the effects of the two
components given separately; moreover, the tumours occurred within the treated
areas, whereas those produced by DMBA alone were outside it.
This peculiar difference in distribution was found in the sites of both benign
and malignant tumours. The predominance of tumours of the head and face has
been observed in this laboratory only in mice treated with a single application of
DMBA to the skin of the back. No other form of treatment of this area, e.g.
repeated applications of hydrocarbons, a single application of a hydrocarbon
followed by repeated applications of croton oil, or single or repeated applications
of other initiators (e.g. urethane, triethylene-melamine, or 8-propiolactone:
see Salaman and Roe, 1953; Roe and Salaman, 1954, 1955), with or without
treatment with croton oil, has resulted in this peculiar distribution of tumouirs.
Our findings with respect to the distribution of tumours following a single applica-
tion of DMBA to the back confirm those of Law (1941). It may also be relevant
that Haddow and his associates (1939) referring to DMBA and a closely related
compound, 5: 9: 10-trimethyl-1: 2-benzanthracene, wrote " It is of interest that
some of the epitheliomata produced by these compounds appear at the edge of
the painted area and not at its centre, suggesting that the optimal conditions for
tumour emergence are in this case dependent on considerable dilution ". It cannot
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be claimed, however, that the faces and heads of our mice were on the edge ofthe
treated area; they were well outside it.
There are a number of possible explanations for the occurrence of tumours on
the head and face of mice treated once with DMBA only (e.g. contamination
during licking of the treated area, combined with a possible higher susceptibility
totumour-induction inthis area, orwiththepossiblepromoting effect ofmechanical
abrasion, etc.), but none of them accounts for the almost complete absence of
tumours of this region in mice treated with DMBA followed by croton oil. All
that can be said is that croton oil applications appear to determine the site of
tumours initiated by DMBA.
Shubik has emphasised, as mentioned above, the high rate of regression of
papillomas produced by a single dose ofDMBA or 20-methylcholanthrene followed
by croton oil (Shubik, 1950), and, in the case of DMBA, our experience confirms
his (Roe, 1956a). This raises the question whether the " set level " of tumour-
incidence, attained in Berenblum's and Shubik's early experiments, which could
not be increased by further croton oil treatment, was really due to the cessation
ofnewtumour appearance, asthey thought, orwas the expression ofanequilibrium
between the development of new tumours and the disappearance of old ones. In
this connection it should be noted that Friedewald and Rous (1950) observed a
gradual increase in the number of tumours on the ears of rabbits treated with
methylcholanthrene for as long as five years, but pointed out that this increase
was the resultant of a steady appearance of new tumours and a steady disap-
pearance, at a slower rate, of older tumours. Doubt has also been cast on the
significance of the " set level" of tumour incidence (see p. 83) by Shubik and
Ritchie (1953), who showed that though the number of tumours finally attained
varied with the concentration of DMBA given as a single initiating dose (though
by no means in simple proportion), it was actually decreased by applying DMBA,
at the same concentration, twice or three times. No relevant data on this property
of DMBA is available from experience in this laboratory, but it has been shown
(Roe and Salaman, 1954)that when urethane is used as initiator, followed by croton
oil, tumour incidence is approximately proportional to the dose of urethane,
whether this is given as a single or as multiple applications. DMBA has a marked
necrotic effect on the skin in doses as high as that used by Shubik and Ritchie
(1953), while urethane has none. It seems probable that the reason for the failure
ofrepeated Iargeinitiating doses ofDMBAtoincrease the final incidence oftumours
attained after promotion is due to this property.
Perhaps some of the initiating agents recently discovered, such as urethane
(Graffi et al., 1953; Salaman and Roe, 1953) triethylene-melamine (Roe and
Salaman, 1955), and others to be described shortly, which have no detectable
damaging effect on the skin, and have so far produced no skin tumours when
applied alone for long periods, will prove more satisfactory tools for the investiga-
tion of the stages of carcinogenesis than the hydrocarbons. Unfortunately no
substituite for croton oil of comparable potency as a promoting agent for mouse
skin has so far been found.
SUMMARY
1. A previous experiment had indicated that a single " initiating " dose of
9, 10-dimethyl-1,2-benzanthracene (DMBA) applied to the dorsal skin of mice,
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followed by a limited course of croton oil applications, gave rise, after a long
latent interval, to malignant tumours in approximately 40 per cent ofthe animals.
The experiment described in the present paper was designed to test whether
division of the " initiating " dose of DMBA into two halves (by halving the
concentration) favoured the induction of malignant tumours. In five test groups
the interval between the half-doses of DMBA ranged from 1 hour to 10 weeks.
2. The results suggested that splitting the initiating dose of DMBA favoured
the induction of malignant tumours, especially when the interval between the
two half-doses was 3 weeks or more. No adequate analytical test of these results
was available, and their statistical significance remains in doubt.
3. Current theories ofthe stages ofcarcinogenesis, in particular those ofBeren-
blum and Shubik (1947a, 1947b), anid Shubik (1950), are discussed in the light of
the results reported in the series of papers of which this is the fourth.
The authors are indebted to Dr. P. Armitage of the Statistical Research Unit,
London School of Hygiene and Tropical Medicine, for advice and assistance in
the statistical analysis of results. They are grateful also to Mr. W. J. Milton,
Miss E. A. Firth, and Mr. J. A. Rawlings for skilled technical assistance.
The expenses of this research were partly defrayed out of a block grant from
the British Empire Cancer Campaign.
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